Protocol No.: 2504150046

A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, Pharmacokinetics, and Efficacy of AMG 732 in Healthy Subjects and Subjects with Moderate-to-Severe Active Thyroid Eye Disease
Principal Investigator
Nguyen, John
Phase
I/II
Age Group
Adult
Applicable Disease Site
Other
Participating Institutions
Eye Institute
West Virginia University
Contact
Shae-Lynn Lewis
Certified Ophthalmic Assistant
Phone: +1 304-974-4102